Reviewed 10 November 2026 for medical education. This is not an individualized prescribing guide; refer to current local product labels and qualified clinicians.
Overview and clinical role
Pentazocine is a synthetic benzomorphan opioid analgesic with mixed agonist–antagonist properties, principally kappa-opioid receptor agonism and weak/partial mu-opioid activity. It has been used for pain severe enough to require an opioid when alternatives are inadequate, but safety risks and the availability of other treatments have limited use. Pentazocine should not be characterized as free of addiction, respiratory depression or overdose risk [1,2].
Mechanisms of action
Kappa receptor activation can produce analgesia, dysphoria and perceptual disturbances. Its low-efficacy mu activity may antagonize the effects of stronger mu agonists in certain circumstances. Opioid receptors are Gi/o-coupled: activation decreases adenylyl cyclase signaling, reduces presynaptic calcium entry and increases potassium conductance. The net result is reduced nociceptive neurotransmission, but also sedation, respiratory depression and gastrointestinal effects. Receptor affinities and clinical responses vary with exposure [1].
Formulations and role of naloxone
Some US oral products contain pentazocine combined with a small amount of naloxone. Naloxone has minimal systemic availability when swallowed as directed; the combination was developed to discourage injection misuse. It is not the same as naloxone overdose rescue and does not eliminate misuse or respiratory-depression hazards. Different dosage forms may have different local approval and availability; clinicians should check product labeling [2].
Pharmacokinetics and use considerations
Pentazocine is absorbed after oral administration, undergoes substantial hepatic metabolism and is eliminated partly through urine as metabolites. Renal/hepatic impairment, frailty and concurrent CNS depressants may increase adverse outcomes. Unlike morphine-equivalent calculations for some full agonists, a direct dose-for-dose substitution is not justified; pain management requires individualized assessment, product-specific instructions and monitoring [1,2].
Adverse effects and interaction hazards
Common reactions include nausea, dizziness, somnolence and sweating. Hallucinations, confusion, dysphoria, hypotension or tachycardia may occur; respiratory depression and overdose can be fatal. Co-administration with alcohol, benzodiazepines, other sedatives or opioids increases danger. Because pentazocine is a mixed opioid agonist–antagonist, it can reduce analgesia or precipitate opioid withdrawal in people receiving full mu agonists. Seizures can occur in susceptible patients [2].
Counselling and overdose response
Physical dependence can occur, and abrupt withdrawal after regular use should be avoided when clinically feasible. Suspected opioid overdose requires emergency medical assistance, breathing support and naloxone when indicated, with observation for recurrent toxicity. Prefer nonopioid treatments when effective, review opioid use disorder risk and offer naloxone education when warranted [1,2].
References
- Brunton LL, Knollmann BC, editors. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 14th ed. McGraw Hill; 2023.
- DailyMed. Pentazocine and naloxone tablets: US prescribing information, revised June 19, 2026. Available from: https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a28450a0-ac93-4235-b9a6-58cdf24773cb
Medical & AI Disclaimer
The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.
We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.